Abstract
Characterization of tumor-to-normal endogenous optical contrast from 3D diffuse optical tomography, neoadjuvant chemotherapy monitoring with additional blood flow information, and 3D fluorescence DOT with exogenous contrast agent injection are presented.
© 2008 Optical Society of America
PDF ArticleMore Like This
Regine Choe, Soren D. Konecky, Alper Corlu, Kijoon Lee, Turgut Durduran, Chao Zhou, Britton Chance, and Arjun G. Yodh
JThA3 Frontiers in Optics (FiO) 2006
Regine Choe, Turgut Durduran, So Hyun Chung, Soren D. Konecky, Saurav Pathak, Han Y. Ban, David R. Busch, Erin M. Buckley, Meeri N. Kim, Angela DeMichele, Carolyn Mies, Mark A. Rosen, Mitchell D. Schnall, and Arjun G. Yodh
BSuB2 Biomedical Optics (BIOMED) 2010
Xiaoping Liang, Qizhi Zhang, Stephen Staal, Stephen Grobmyer, and Huabei Jiang
JMA81 Biomedical Optics (BIOMED) 2010